Surgical Science Sweden AB (publ) financials at a glance

+ Portfolio

The revenue of Surgical Science Sweden AB (publ) is reported as 0.88285 billion Kronor in the fiscal year 2023. The earnings were 4.59 Kronor per share in 2023, which was 24.39 higher than 2022. And about 0.22824 billion Kronor are reported as free cash flow in the financials of Surgical Science Sweden AB (publ) 2023. No dividends were paid to the shareholders of the Surgical Science Sweden AB (publ) stock OM:SUS in the financial year 2023.

kr882.85M

Revenue

kr4.59

Earnings Per Share

69.42%

Gross Margin %

kr193.74M

Free Cash Flow

Revenue

882.85

Earnings Per Share

4.59

Gross Margin %

69.42

Free Cash Flow

193.74

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017
Rev.	Revenue	N/A	kr882.85M	kr802.54M	kr366.78M	kr104.80M	kr101.52M	kr65.70M	kr58.00M
GM %	Gross Margin %	67.87%	69.42%	66.23%	72.51%	84.32%	82.33%	74.84%	64.46%
OM	Operating Margin	22.44%	21.67%	20.29%	22.57%	19.06%	16.03%	-6.19%	-7.31%
EPS	Earnings Per Share	kr4.96	kr4.59	kr3.69	kr2.69	kr0.45	kr0.43	kr-0.19	kr-0.12
Div.	Dividends	N/A	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00	kr0.00
PR %	Payout Ratio %	0	0.00%	0.00%	0.00%	0.00%	0	0	0
Sha.	Shares	N/AM	51.03M	50.8M	50.8M	34.49M	33.62M	24.32M	24.32M
OCF	Operating Cash Flow	N/A	kr238.70M	kr114.50M	kr39.08M	kr23.23M	kr55.20M	kr6.88M	kr7.94M
FCF	Free Cash Flow	N/A	kr193.74M	kr94.30M	kr24.71M	kr14.53M	kr54.88M	kr5.39M	kr4.69M
FCFS	Free Cash Flow Per Share	kr4.55	kr3.81	kr1.87	kr0.58	kr0.42	kr1.64	kr-0.07	kr-0.06

Surgical Science Sweden AB (publ) financials at a glance

Financials

Discover